Trulicity 1.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4E8M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,266
Award facts
- Contract value 100% obligated
- $15,266.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,266.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen (0.5 mL units), a diabetes medication. The contract was awarded on January 12, 2026, as a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and no set-aside designation was used. The place of performance is located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at up to $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The non-set-aside, competitively awarded delivery order demonstrates AmerisourceBergen's established capability to fulfill federal pharmaceutical procurement requirements through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F4E8M?
SPE2DR26F4E8M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F4E8M worth?
The government has obligated $15,266 on SPE2DR26F4E8M.
Is contract SPE2DR26F4E8M an order under another contract?
Yes. SPE2DR26F4E8M is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E8M competed?
The extent of competition for SPE2DR26F4E8M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award